Consolidated Statements of Shareholders’ Equity - USD ($) shares in Millions, $ in Millions		Total	Ordinary Shares and Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss, Net of Tax	Non-redeemable Non-controlling Interests
Beginning Balance (in shares) at Dec. 31, 2022			205.4
Beginning Balance at Dec. 31, 2022		$ (429)	$ 6,866	$ (2,772)	$ (4,623)	$ 100
Increase (Decrease) in Shareholders' Equity
Net income		2,628		2,564		64
Shares issued — employee stock compensation plans (in shares)			1.6
Shares issued — employee stock compensation plans		(169)	$ (168)	(1)
Shares repurchased (in shares)			(8.4)
Shares repurchased		(2,700)		(2,700)
Share-based compensation expense		438	$ 438
Dividends to shareholders		(490)		(490)
Net change in fair value of financial instruments		13			13
Net foreign currency translation adjustments		276			277	(1)
Net postretirement benefit obligation		(40)			(40)
Net purchases of shares from nonredeemable noncontrolling interests		(213)	$ (190)			(23)
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock		(56)				(56)
Ending Balance (in shares) at Dec. 31, 2023			198.6
Ending Balance at Dec. 31, 2023		(742)	$ 6,946	(3,399)	(4,373)	84
Increase (Decrease) in Shareholders' Equity
Net income		2,715		2,654		61
Shares issued - NFP Transaction (In shares)			19.0
Shares issued - NFP Transaction		5,882	$ 5,882
Shares issued — employee stock compensation plans (in shares)			1.5
Shares issued — employee stock compensation plans		$ (124)	$ (123)	(1)
Shares repurchased (in shares)		(3.1)	(3.1)
Shares repurchased		$ (1,000)		(1,000)
Share-based compensation expense		474	$ 474
Dividends to shareholders		(563)		(563)
Net change in fair value of financial instruments		72			72
Net foreign currency translation adjustments		(467)			(467)	0
Net postretirement benefit obligation		23			23
Net purchases of shares from nonredeemable noncontrolling interests		83	(1)			84
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock		(45)				(45)
Adjustments to redeemable noncontrolling interest		$ (3)	$ (3)
Ending Balance (in shares) at Dec. 31, 2024		216.0	216.0
Ending Balance at Dec. 31, 2024		$ 6,305	$ 13,175	(2,309)	(4,745)	184
Increase (Decrease) in Shareholders' Equity
Net income	[1]	3,754		3,695		59
Shares issued — employee stock compensation plans (in shares)			1.2
Shares issued — employee stock compensation plans		$ (139)	$ (137)	(2)
Shares repurchased (in shares)		(2.7)	(2.7)
Shares repurchased		$ (1,000)		(1,000)
Share-based compensation expense		432	$ 432
Dividends to shareholders		(629)		(629)
Net change in fair value of financial instruments		4			4
Net foreign currency translation adjustments		826			826
Net postretirement benefit obligation		72			72
Net purchases of shares from nonredeemable noncontrolling interests		(85)	(10)			(75)
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock		(61)				(61)
Adjustments to redeemable noncontrolling interest		$ (20)	$ (20)
Ending Balance (in shares) at Dec. 31, 2025		214.5	214.5
Ending Balance at Dec. 31, 2025		$ 9,459	$ 13,440	$ (245)	$ (3,843)	$ 107

[1] For the years ended December 31, 2025, 2024, and 2023, the Company’s Net income totaled $3.8 billion, $2.7 billion, and $2.6 billion, which included $(4) million, $5 million, and $0 million of Net income (loss) related to redeemable noncontrolling interests, respectively.